Alternative medicine may have the cure for all those who fight against cancer – the small Chinese herb known is another gift powerful nature of the growing list of cancer murderers. According to studies published in Life Sciences, Cancer Letters and Anticancer Drugs, artemisinin, a derivative of the wormwood plant commonly used in Chinese medicine, has the ability to kill cancer cells at a rate of 12,000 cells cancer for every healthy cell.
Henry Lai and his team of researchers at the University of Washington synthesize the compound, which uses the appetite of a cancer cell iron to mark it as a target. Best of artemisinin is selectively kill cancer cells without causing any damage to healthy cells.
“By itself, artemisinin is about 100 times more selective in killing cancer cells compared to normal cells. Artemisinin is 34,000 times more potent in killing cancer cells compared to their normal cousins. so the tagging process appears to have greatly increased the potency of the properties to fight cancer artemisinin. “- Henry Lai
Although the compound is licensed to Holley Pharmaceuticals, no records about being used for the treatment of cancer in humans.
“we call it a Trojan horse because the cancer cell recognizes transferrin as a natural, harmless protein So the cell picks up the compound without knowing that a bomb (ACTs) is hidden inside..” – Henry Lai
centuries the wormwood extract was used in China as a cure for many diseases and health conditions. Through the years its use is reduced to a minimum and it was rediscovered thanks to an ancient manuscript containing medical remedies. The extract kills 12,000 cancer cells for every healthy cell, which means it could be modified into a drug with minimal side effects or.
“The compound is being licensed from the University of Washington to Artemisia Biomedical Inc., a company Lai, Sasaki and Narendra Singh, UW associate professor of bioengineering, founded in Newcastle, Washington for development and marketing. human trials are at least several years away. artemisinin is readily available, Sasaki said, and is expected to compound over time can be manufactured at low cost to help cancer patients in countries developing. “
” artemisinin reacts with iron to form free radicals that kill cells. Since the cancer cells uptake relatively large amounts of iron than normal cells, which are more susceptible to the toxic effect artemisinin. in previous research, we have shown that artemisinin is more attracted to that normal cells cancerous cells. in the present investigation, covalently bound artemisinin to transferrin iron plasma glycoprotein-carying.
Transferrin is transported into cells via endocytosis and cell receptors mid cancer express significantly more transferrin receptors on their cell surface and transferrin endocytose more than normal cells. Therefore, the hypothesis that by tagging artemisinin to transferrin, iron and artemisinin would be transported to the cancer cells in a single package. Once inside a cell, iron is released and can react readily with artemisinin near labeled transferrin.
This would increase the toxicity and selectivity of artemisinin to cancer cells. It was found that artemisinin holotransferrin labeling when compared with artemisinin, was very potent and selective in killing cancer cells. . Therefore, this “-labeled compound” could potentially become an effective chemotherapeutic agent for cancer treatment “
Another summary reads as follows:
” Our results show that artemisinin interruption of the expression of the transcription factor half E2F1 the cell cycle arrest of cells human breast cancer and represents a transcriptional pathway critical for which artemisinin controls the growth of cancer cells of human reproduction. “
artemisinin is approved by the FDA for the treatment of malaria, and is very safe and easy to use. It is cheap and effective in all cancers, but its use is not common to medicine. it is time to look beyond radiation, surgery and chemotherapy for cancer treatment.